|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Htg Molecular Diagnostics, Inc (HTGM) |
|
|
$0.28 0.00 (0.00%) as of 4:30 Fri 11/20
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
9,000,000 |
| Market
Cap: |
2.56(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2849 - $0.2849 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile HTG Molecular Diagnostics is a commercial stage RNA platform-based life sciences company focused on developing medicine. Co.'s product and service solutions are based on its digital HTG EdgeSeq technology that enables RNA profiling using a small amount of biological sample, in liquid or solid forms. Co. markets proprietary molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. Co.'s marketed panels include: HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq Precision Immuno-Oncology Panel; HTG Lung Fusions Assay; HTG Autoimmune Panel; HTG EdgeSeq Immuno-Oncology Assay; and HTG Mouse mRNA Tumor Response Panel.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
888 |
888 |
| Total Sell Value |
$0 |
$0 |
$710 |
$710 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
1 |
1 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lubniewski John L |
President & COO |
• – – |
2018-10-01 |
4 |
D |
$4.52 |
$4,163 |
D/D |
(921) |
161,858 |
|
- |
|
| Johnson Tim B |
CEO |
• • – |
2018-10-01 |
4 |
D |
$4.52 |
$6,242 |
D/D |
(1,381) |
259,128 |
|
- |
|
| Hanham Ann |
Director |
– • – |
2018-09-11 |
4 |
A |
$4.34 |
$9,999 |
D/D |
2,304 |
4,804 |
|
- |
|
| Johnson Tim B |
CEO |
• • – |
2018-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
260,509 |
|
- |
|
| Lubniewski John L |
President & COO |
• – – |
2018-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
162,779 |
|
- |
|
| Mcmeans Shaun D |
SVP, Finance & Admin. & CFO |
• – – |
2018-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
117,087 |
|
- |
|
| Hardison Don M |
Director |
– • – |
2018-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
10,000 |
|
- |
|
| Lafrance James T |
Director |
– • – |
2018-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
10,000 |
|
- |
|
| Hanham Ann |
Director |
– • – |
2018-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| George Harry A. |
Director |
– • – |
2018-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
36,530 |
|
- |
|
| Mccracken Lee R. |
Director |
– • – |
2018-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| Johnson Tim B |
CEO |
• • – |
2018-06-08 |
4 |
A |
$1.57 |
$1,239 |
D/D |
788 |
185,509 |
|
- |
|
| Roche Patrick C. |
SVP Medical/Scientific Affairs |
• – – |
2018-06-08 |
4 |
A |
$1.57 |
$1,239 |
D/D |
788 |
43,421 |
|
- |
|
| Lubniewski John L |
President & COO |
• – – |
2018-06-08 |
4 |
A |
$1.57 |
$1,239 |
D/D |
788 |
112,779 |
|
- |
|
| Mcmeans Shaun D |
SVP, Finance & Admin. & CFO |
• – – |
2018-06-08 |
4 |
A |
$1.57 |
$1,061 |
D/D |
675 |
92,087 |
|
- |
|
| Gordon Debra A |
SVP, Chief Legal Counsel |
• – – |
2018-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
29,719 |
72,552 |
|
- |
|
| Mcmeans Shaun D |
SVP, Finance & Admin. & CFO |
• – – |
2018-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
48,291 |
91,412 |
|
- |
|
| Lubniewski John L |
SVP, Chief Business Officer |
• – – |
2018-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
63,483 |
111,991 |
|
- |
|
| Johnson Tim B |
President & CEO |
• • – |
2018-01-29 |
4 |
D |
$3.84 |
$133,513 |
D/D |
(34,769) |
184,721 |
|
- |
|
| Johnson Tim B |
President & CEO |
• • – |
2018-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
118,058 |
219,490 |
|
- |
|
| Roche Patrick C. |
SVP Research & Development |
• – – |
2017-12-08 |
4 |
A |
$1.61 |
$1,314 |
D/D |
818 |
42,633 |
|
- |
|
| Johnson Tim B |
President & CEO |
• • – |
2017-12-08 |
4 |
A |
$1.61 |
$1,314 |
D/D |
818 |
101,432 |
|
- |
|
| Gordon Debra A |
V.P. and Chief Legal Counsel |
• – – |
2017-12-08 |
4 |
A |
$1.61 |
$1,314 |
D/D |
818 |
42,833 |
|
- |
|
| Mcmeans Shaun D |
VP, Finance & Admin. & CFO |
• – – |
2017-12-08 |
4 |
A |
$1.61 |
$1,314 |
D/D |
818 |
43,121 |
|
- |
|
| Lubniewski John L |
Chief Business Officer |
• – – |
2017-12-08 |
4 |
A |
$1.61 |
$1,314 |
D/D |
818 |
48,508 |
|
- |
|
227 Records found
|
|
Page 5 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
